The global transplantation market was estimated at USD 12.5 billion in 2021 and is expected to surpass around USD 31 billion by 2030 with a CAGR of 9.4% from 2022 to 2030.
The global transplantation market was estimated at USD 12.5 billion in 2021 and is expected to surpass around USD 31 billion by 2030 with a CAGR of 9.4% from 2022 to 2030. Growing incidence of organ failure has resulted in massive growth in the transplantation market.
Rising demand for transplant products such as tissue products, immunosuppressants, and organ preservation solutions is a major factor anticipated to boost the market’s growth during the forecast period. Thus, many biotechnology and medical device companies have begun to concentrate on the development of advanced transplant products for the management of organ failure.
Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/37243
Technological advancement in organ transplantation methods is another major factor supporting the market growth. The development of novel & improved transplant products such as tissue products and surgical instruments has majorly contributed to the expansion of the sector.
In addition, the introduction of advanced tissue products such as DeNovo NT Graft, Chondrofix Osteochondral Allograft, and DuraMatrix Collagen Dura Substitute Membrane provides higher benefits during treatment. In addition, computerized support systems with advanced systems and software allow easy & effective maintenance of tissues. Thus, the availability of such advanced techniques supports an increase in the number of organ transplant procedures.
Scope of the Transplantation Market
| Report Coverage | Details |
| Market Size by 2030 | USD 31 billion |
| Growth Rate from 2022 to 2030 | CAGR of 9.4% |
| Base Year | 2021 |
| Forecast Data | 2022 to 2030 |
| Segmentation | Profuct, Application, End User, Region |
Product Insight
Tissue products were the highest revenue-generating segment in 2021 with a market share of 57.8%. Major products used for tissue or organ transplantation are tissue products, immunosuppressants, and preservation solutions. The increasing number of transplantation procedures such as that of cochlear, heart valves, bone marrow, and orthopedic soft tissues is attributed to the growth of the segment. In addition, new product development is also fueling market growth.
The preservation solutions segment is expected to exhibit significant growth during the study period due to rising government support for stem cell research and the high application of these products to improve the physiological function of organs. In addition, rising cases of organ failure, increasing organ transplant procedures, and escalating number of organ donations worldwide are expected to drive the segment growth.
Ask here for more details@ https://www.visionresearchreports.com/report/enquiry/37243
Application Insight
Tissue transplantation dominates the market with market size of 7.6 billion in 2021. This is due to the fact that the replacement of skin, cornea, bones, heart valves, tendons, nerves, and veins are most commonly performed procedure worldwide. The escalating number of burn and accident cases is expected to propel the demand for tissue products.
The organ transplantation segment is expected to show a lucrative growth rate during the forecast period. The increasing number of organ transplantations globally as well as the repetitive purchase of immunosuppressants is anticipated to boost the market growth in the near future. For instance, in 2017, around 90,306 kidney transplant procedures were performed globally.
End-Use Insight
The hospitals segment held the largest market share of 49.6% in the year 2021. A large number of organ and tissue transplant procedures are conducted at hospitals as they are primary treatment centers. Additionally, the emergence of hospitals with developed infrastructure is further expected to fuel market growth.
The number of transplant centers is expected to exhibit the highest growth during the forecast period. Escalating transplantation procedures have triggered the need for an increased number of healthcare centers catering to the unmet needs of the patients. Also, rising government initiatives to encourage organ donation are projected to propel market growth.
Regional Insights
In 2021, North America dominated the transplantation market with a market share of 39.4% and is expected to maintain its dominance throughout the study period. Well-developed healthcare facilities and the local presence of many large biotechnology and medical devices companies, such as Arthrex, Inc.; Zimmer Biomet; Medtronic; Novartis AG; and Stryker are supporting the market growth.
Asia Pacific market is projected to rise at the highest rate during the forecast period, owing to the growing research on stem cells to develop in-vitro tissue and organs as well as developing healthcare infrastructure in Asian countries such as India, Thailand, Philippines, Indonesia.
Key Players
- Stryker Corp.
- Medtronic PLC
- AbbVie Inc.
- Zimmer Biomet
- Novartis International AG
- 21st Century Medicine
- Biolife Solutions
- Teva Pharmaceutical
- Veloxis Pharmaceuticals
Market Segmentation
- Product Type Outlook
- Tissue Products
- Immunosuppressive Drugs
- Preservation Solutions
- Application Type Outlook
- Organ Transplant
- Tissue Transplant
- End-use Outlook
- Hospitals
- Transplant Centers
- Others
- Regional Outlook
- North America
- Europe
- Asia Pacific
- Latin America
- MEA
Click Here to View Full Report Table of Contents
Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/37243
You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333